Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Cancer Res Clin Oncol ; 135(3): 459-66, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18758815

RESUMO

INTRODUCTION: Anthracyline-based chemotherapy is the treatment of choice for patients with aggressive B-cell non-Hodgkin's lymphoma (NHL). However, anthracyclines have been associated with long-term cardiac toxicity. METHODS: We conducted a study using a sequential combination chemotherapy with a reduced cumulative dose of anthracyclines in younger patients with good-prognosis aggressive NHL. Chemotherapy consisted of one cycle of vincristine, ifosfamide, etoposide, and dexamethasone, followed by three cycles of epirubicin, cyclophosphamide, vincristine, and dexamethasone, and a fifth cycle containing carboplatin, etoposide, and dexamethasone. 86 patients were treated, 65 without and 21 with additional rituximab. Consolidating involved-field irradiation was applied in patients with stage I/II, bulky disease, or localized residual lymphoma. RESULTS: Complete and partial remissions were achieved in 67 and 27% of patients, respectively, and the 3-year event-free and overall survival estimates were 75 and 87%. The survival estimates were substantially better in patients who received rituximab. Main toxicity was grade 3/4 leukocytopenia in 89% patients with neutropenic fever in 30%. Two patients died of septic shock. CONCLUSION: The treatment appears to be effective in this group of patients. The hematological toxicities, particularly after the first and fifth cycle, require the use of G-CSF and/or a dose reduction in selected patients.


Assuntos
Antraciclinas/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/toxicidade , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Linfoma de Células B/tratamento farmacológico , Adolescente , Adulto , Antraciclinas/administração & dosagem , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais/toxicidade , Anticorpos Monoclonais Murinos , Antineoplásicos/uso terapêutico , Antineoplásicos/toxicidade , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Ciclofosfamida/administração & dosagem , Progressão da Doença , Intervalo Livre de Doença , Relação Dose-Resposta a Droga , Doxorrubicina/administração & dosagem , Feminino , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Humanos , Linfoma de Células B/mortalidade , Linfoma de Células B/patologia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Prednisona/administração & dosagem , Prognóstico , Indução de Remissão , Rituximab , Análise de Sobrevida , Sobreviventes , Vincristina/administração & dosagem , Adulto Jovem
2.
Med Klin (Munich) ; 93(2): 107-10, 1998 Feb 15.
Artigo em Alemão | MEDLINE | ID: mdl-9545709

RESUMO

BACKGROUND: Local vascular complications after transfemoral cardiac catheterization occur with an incidence of 5%. Most commonly these lesions are pseudoaneurysms, av-fistulas, arterial dissections or direct vascular injuries. Undiagnosed vascular lesions can lead to fatal consequences especially in patients with chronic heart failure by av-fistula with significant shunt volume. CASE REPORT: We report a vascular complication of combined pseudoaneurysm and av-fistula originated from the pseudoaneurysm. The lesion was diagnosed by color Doppler ultrasound. CONCLUSION: The suspicion of a vascular lesion after vascular catheterization should immediately lead to color Doppler ultrasound. Noninvasive duplexsonography will lead to early diagnosis of vascular complications and prompt further surgical or conservative intervention with reduction of long-term sequela and morbidity.


Assuntos
Falso Aneurisma/etiologia , Angioplastia Coronária com Balão/instrumentação , Fístula Arteriovenosa/etiologia , Cateterismo Cardíaco/instrumentação , Artéria Femoral/lesões , Veia Femoral/lesões , Idoso , Falso Aneurisma/diagnóstico por imagem , Fístula Arteriovenosa/diagnóstico por imagem , Feminino , Artéria Femoral/diagnóstico por imagem , Veia Femoral/diagnóstico por imagem , Humanos , Stents , Ultrassonografia Doppler em Cores
3.
Eur Radiol ; 7(8): 1199-206, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9377500

RESUMO

Hemochromatosis is a multisystem disorder produced by the excessive accumulation of iron in visceral organs and the musculoskeletal system. Clinically the disease may be silent, but characteristic radiological features may point to the diagnosis. The increased iron stores in the organs involved, especially in the liver and pancreas, result in an increased attenuation at unenhanced CT and an decreased signal intensity at MR imaging. Hemochromatosis arthropathy includes degenerative osteoarthritis and chondrocalcinosis. The distribution of the arthropathy is distinctive, but not unique, frequently affecting the second and third metacarpophalangeal joints of the hand.


Assuntos
Hemocromatose/diagnóstico , Artropatias/diagnóstico , Hepatopatias/diagnóstico , Pancreatopatias/diagnóstico , Adulto , Condrocalcinose/diagnóstico , Condrocalcinose/etiologia , Feminino , Hemocromatose/complicações , Humanos , Artropatias/etiologia , Hepatopatias/etiologia , Imageamento por Ressonância Magnética , Masculino , Articulação Metacarpofalângica/diagnóstico por imagem , Pessoa de Meia-Idade , Osteoartrite/diagnóstico , Osteoartrite/etiologia , Pancreatopatias/etiologia , Tomografia Computadorizada por Raios X
5.
Pacing Clin Electrophysiol ; 17(9): 1565-8, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7991430

RESUMO

A 63-year-old male received a transvenous temporary pacemaker for bradyarrhythmia following mitral valve replacement and tricuspid valve annuloplasty. A transvenous permanent pacemaker was implanted the following day due to persistence of the bradyarrythmia and pacemaker dependency of the patient. Later the same day during removal of the temporary pacing electrode the permanent pacing lead was dislodged and had to be operatively repositioned. To avoid this complication, the position of pacemaker leads should be checked postoperatively with a frontal and lateral chest radiograph, and fluoroscopy should be used during removal of a temporary lead.


Assuntos
Estimulação Cardíaca Artificial , Eletrodos Implantados , Marca-Passo Artificial , Bradicardia/terapia , Eletrocardiografia , Eletrodos Implantados/efeitos adversos , Falha de Equipamento , Fluoroscopia , Coração/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Marca-Passo Artificial/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA